Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
LAVA Therapeutics (LVTX)
NASDAQ:LVTX
LAVA Therapeutics (LVTX) Stock Price & Analysis
66 Followers
LVTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.60 - $7.38
Previous Close$1.66
Volume21.00K
Average Volume (3M)60.58K
Market Cap
$42.82M
Enterprise Value-$45.27M
Total Cash (Recent Filing)$92.72M
Total Debt (Recent Filing)$4.63M
Price to Earnings (P/E)N/A
Beta-0.11
Next Earnings
Mar 23, 2023EPS Estimate
-$0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,289,087
10 Day Avg. Volume88,600
30 Day Avg. Volume60,577
Standard Deviation0.26
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.66
Price to Sales (P/S)3.66
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.58
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.54
Forecast
1Y Price Target
$10.33Price Target Upside545.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
LAVA Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LVTX FAQ
What was LAVA Therapeutics’s price range in the past 12 months?
LAVA Therapeutics lowest stock price was $1.60 and its highest was $7.38 in the past 12 months.
What is LAVA Therapeutics’s market cap?
Currently, no data Available
When is LAVA Therapeutics’s upcoming earnings report date?
LAVA Therapeutics’s upcoming earnings report date is Mar 23, 2023 which is in 2 days.
How were LAVA Therapeutics’s earnings last quarter?
LAVA Therapeutics released its earnings results on Nov 16, 2022. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of -$0.532 by $0.572.
Is LAVA Therapeutics overvalued?
According to Wall Street analysts LAVA Therapeutics’s price is currently Undervalued.
Does LAVA Therapeutics pay dividends?
LAVA Therapeutics does not currently pay dividends.
What is LAVA Therapeutics’s EPS estimate?
LAVA Therapeutics’s EPS estimate is -$0.6.
How many shares outstanding does LAVA Therapeutics have?
LAVA Therapeutics has 25,797,735 shares outstanding.
What happened to LAVA Therapeutics’s price movement after its last earnings report?
LAVA Therapeutics reported an EPS of $0.04 in its last earnings report, beating expectations of -$0.532. Following the earnings report the stock price went up 3.333%.
Which hedge fund is a major shareholder of LAVA Therapeutics?
Among the largest hedge funds holding LAVA Therapeutics’s share is Falcon Edge Capital, LP. It holds LAVA Therapeutics’s shares valued at 418K.
---
LAVA Therapeutics Stock Smart Score
Company Description
LAVA Therapeutics
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
---
---